No phaseSuspended
IonMAN II Trial- Early Feasibility Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System
- Sponsor
- Medinol Ltd. (Industry)
- Enrolment
- 30 planned
- Conditions
- Coronary Stenosis; Coronary Artery Disease
- Interventions
- IoNIR Ridaforolimus-Eluting Coronary Stent System
- Ages
- adults, older adults
- Registry
- NCT06071702
Full record on ClinicalTrials.gov
From the registry
This is a prospective, multi-center, single-arm, open-label, early feasibility study to provide preliminary evidence for the safety and efficacy of the novel IoNIR stent system
Primary outcomes
- In-stent Late Loss (LL)
- Target Lesion Failure
History
Study completion expected
Last registry update
Started
Primary completion
Registered